Clinical Trials in Italy / NCT06595212
Unknown Observational

Genetics and Environment iNtersection In the ALS-FTD Spectrum: an Italian Twins Cohort studY With a Multi-Omics Approach

NCT06595212 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2024-01-29
Last updated
2025-02-04

Condition(s) studied

ALSFTD

Investigational drug(s) / intervention(s)

multiomic profile to assess genetic and environmental risk factiors

multiomic profile to assess genetic and environmental risk factiors: Genomic, epigenetic, proteomic, microbiome, immunology, biomarker, metabolite, pesticide, metal, and metalloid investigations will be conducted. The twins will be followed longitudinally from a clinical perspective, with biological sample collections to assess discordance and identify early disease signatures in unaffected individuals.

Study summary

The goal of this study is to learn from discordant twins affected by Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia the contribution of genetic background versus environmental exposure. The main questions it aims to answer is:

* How far does the genetic background explain the onset of ALS/FTD in discordant twins?
* Which environmental factors and events occurring in post-fetal life influence the onset or progression of this neurodegenerative condition? Participants with ALS and/or FTD with a monozygotic or dizygotic twin willing to contribute to this research will be followed up for two years by specialized Motor Neuron Disorders centers in Italy, donating biological specimen for -omic sciences analysis, and checking out if prodromal signs/symptoms of these two conditions will develop during time.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age \>18 yrs * Presence of MZ or DZ twins in the family both willing to participate in the study and able to provide informed consent * At least one twin is affected by ALS as defined by Gold Coast Criteria (Shefner et al., 2020) and/or by FTD as defined by Strong and colleagues (Strong et al., 2017) * Subjects able and willing to comply with study procedures as per protocol * Subjects able to understand, and capable of providing informed consent at screening visit before any protocol-specific procedures Exclusion Criteria: * Unwillingness to perform assessments as stated in the protocol at least during baseline visit for both twins * Unwillingness to donate biological samples collected at periphery (lumbar puncture excluded) for both twins * Women who are pregnant or breastfeeding

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Azienda Ospedaliero-Universitaria di Modena Modena Italy Recruiting
Azienda Ospedaliero-Universitaria Policlinico P. Giaccone di Palermo Palermo Italy Recruiting
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino Torino Italy Recruiting

More Azienda Ospedaliero-Universitaria di Modena trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06595212 on ClinicalTrials.gov ↗ ← All trials in Italy